Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma

Skin Research and Technology

Volumn 19, Issue 2, 2013, Pages 75-83

  Mohr, Peter ^a   Birgersson, Ulrik ^b,c   Berking, Carola ^d   Henderson, Catriona ^e   Trefzer, Uwe ^f   Kemeny, Lajos ^g   Sunderkötter, Cord ^h   Dirschka, Thomas ⁱ   Motley, Richard ^j   Frohm Nilsson, Margareta ^k   Reinhold, Uwe ^l   Loquai, Carmen ^m   Braun, Ralph ⁿ   Nyberg, Filippa ^o   Paoli, John ^p  

^a Elbe Klinikum Buxtehude   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SciBase AB   (Sweden)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF SZEGED   (Hungary)

^h UNIVERSITY HOSPITAL MÜNSTER   (Germany)

ⁱ Dermatologische Praxis   (Germany)

^j UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY OF BONN   (Germany)

^m JOHANNES GUTENBERG UNIVERSITY   (Germany)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^p SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Diagnostics; Electric impedance; Melanoma; Sensitivity and specificity; Skin cancer

Indexed keywords

AUTOMATIC ASSESSMENT; CLASSIFICATION ALGORITHM; ELECTRICAL IMPEDANCE; ELECTRICAL IMPEDANCE SPECTROSCOPY; MELANOMA; SENSITIVITY AND SPECIFICITY; SKIN CANCERS; STATISTICALLY SIGNIFICANT DIFFERENCE;

ALGORITHMS; CALIBRATION; DIAGNOSTIC PRODUCTS; ELECTRIC IMPEDANCE; ELECTRIC IMPEDANCE MEASUREMENT; ONCOLOGY; PLASMA DIAGNOSTICS; SPECTROSCOPY;

DERMATOLOGY;

ARTICLE; CALIBRATION; CLASSIFICATION ALGORITHM; CUTANEOUS MELANOMA; DIAGNOSTIC ACCURACY; DYSPLASTIC NEVUS; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; HUMAN; NON MELANOMA SKIN CANCER; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; DIELECTRIC SPECTROSCOPY; EUROPE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84876305614     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/srt.12008     Document Type: Article

References (46)

1. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69-82.
2. Karlsson MA, Wahlgren CF, Wiklund K, Rodvall Y. Parental sun-protective regimens and prevalence of common melanocytic naevi among 7-year-old children in Sweden: changes over a 5-year period. Br J Dermatol 2011; 164: 830-837.
3. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
4. Pleasance ED, Cheetham RK, Stephens PJ et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2009; 463: 191-196.
5. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004; 351: 998-1012.
6. Baade P, Meng X, Youlden D, Aitken J, Youl P. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006. Int J Cancer 2012; 130: 170-178.
7. Soyer HP, Smolle J, Hödl S, Pachernegg H, Kerl H. Surface microscopy. A new approach to the diagnosis of cutaneous pigmented lesions. Am J Dermatopathol 1989; 11: 1-10.
8. Piccolo D, Ferrari A, Peris K, Diadone R, Ruggeri B, Chimenti S. Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: a comparative study. Br J Dermatol 2002; 147: 481-486.
9. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3: 159-165.
10. Carli P, De Giorgi V, Crocetti E, Mannone F, Massi D, Chiarugi A, Giannotti B. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol 2004; 150: 687-692.
11. Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159: 669-676.
12. Rigel D S, Russak J, Friedman R. The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. CA Cancer J Clin 2010; 60: 301-316.
13. Åberg P, Birgersson U, Elsner P, Mohr P, Ollmar S. Electrical impedance spectroscopy and the diagnostic accuracy for malignant melanoma. Exp Dermatol 2011; 20: 648-652.
14. Scholkopf B, Smola A. Learning with kernels. Cambridge Massachusetts: MIT Press, 2002.
15. Schindewolf T, Schiffner R, Stolz W, Albert R, Abmayr W, Harms H. Evaluation of different image acquisition techniques for a computer vision system in the diagnosis of malignant melanoma. J Am Acad Dermatol 1994; 31: 33-41.
16. Cristofolini M, Zumiani G, Bauer P, Cristofolini P, Boi S, Micciolo R. Dermatoscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. Melanoma Res 1994; 4: 391-394.
17. Soyer HP, Smolle J, Leitinger G, Rieger E, Kerl H. Diagnostic reliability of dermoscopic criteria for detecting malignant melanoma. Dermatology 1995; 190: 25-30.
18. Binder M, Kittler H, Seeber A, Steiner A, Pehamberger H, Wolff K. Epiluminescence microscopybased classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Res 1998; 8: 261-266.
19. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions: comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134: 1563-1570.
20. Seidenari S, Pellicani G, Gianetti A. Digital videomicroscopy and image analysis with automatic classification for detection of thin melanomas. Melanoma Res 1999; 9: 163-171.
21. Andreassi L, Perotti R, Rubegni P et al. Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma. Arch Dermatol 1999; 135: 1459-1465.
22. Bataille V, Sasieni P, Curley RK, Cook MG, Marsden RA. Melanoma yield, number of biopsies and missed melanomas in a British teaching hospital pigmented lesion clinic: a 9-year retrospective study. Br J Dermatol 1999; 140: 243-248.
23. Lorentzen H, Weismann K, Petersen CS, Larsen FG, Secher L, Skødt V. Clinical and dermatoscopic diagnosis of malignant melanoma: assessed by expert and non-expert groups. Acta Derm Venereol 1999; 79: 301-304.
24. Collas H, Delbarre M, De Preville PA et al. Dermatologists of the Postgraduate Association of Haute-Normandie. Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Ann Dermatol Venereol 1999; 126: 494-500.
25. Benelli C, Roscetti E, Dal Pozzo V. Reproducibility of a dermoscopic method (7FFM) for the diagnosis of malignant melanoma. Eur J Dermatol 2000; 10: 110-114.
26. Stanganelli I, Serafini M, Bucchi LA. A cancer-registry-assisted evaluation of the accuracy of digital epiluminescence microscopy associated with clinical examination of pigmented skin lesions. Dermatology 2000; 200: 11-16.
27. Ganster H, Pinz A, Röhrer R, Wildling E, Binder M, Kittler H. Automated melanoma recognition. IEEE Trans Med Imaging 2001; 3: 233-239.
28. Megahed M, Schön M, Selimovic D, Schön MP. Reliability of diagnosis of melanoma in situ. Lancet 2002; 359: 1921-1922.
29. Carli P, Nardini P, Crocetti E, De Giorgi V, Giannotti B. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res 2004; 14: 403-407.
30. Argenziano G, Soyer HP, Chimenti S et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48: 679-693.
31. English DR, Del Mar C, Burton RC. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust 2004; 180: 16-19.
32. Robinson JK, Nickoloff BJ. Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol 2004; 140: 49-56.
33. Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005; 141: 998-1006.
34. Menzies SW, Bischof L, Talbot H et al. The performance of solarscan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma. Arch Dermatol 2005; 141: 1388-1396.
35. Chen SC, Pennie ML, Kolm P et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 2006; 21: 678-682.
36. Nathansohn N, Orenstein A, Trau H, Liran A, Schachter J. Pigmented lesions clinic for early detection of melanoma: preliminary results. Isr Med Assoc J 2007; 9: 708-712.
37. Fuller SR, Bowen GM, Tanner B, Florell SR, Grossman D. Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg 2007; 33: 1198-1206.
38. Friedman RJ, Gutkowicz-Krusin D, Farber MJ et al. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol 2008; 144: 476-482.
39. Warshaw EM, Lederle FA, Grill JP et al. Accuracy of teledermatology for pigmented neoplasms. J Am Acad Dermatol 2009; 61: 753-765.
40. Menzies SW, Emery J, Staples M et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009; 161: 1270-1207.
41. Rosendahl C, Tschandl P, Cameron A, Kittler H. Diagnostic accuracy of dermatoscopy for melanocytic and nonmelanocytic pigmented lesions. J Am Acad Dermatol 2011; 64: 1068-1073.
42. Moheit G, Cognetta A, Ferris L et al. The performance of Melafind. Arch Dermatol 2011; 147: 188-194.
43. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528-531.
44. Soyer P, Massone C, Ferrara G, Argenziano G. Limitations of histopathologic analysis in the recognition of melanoma: a plea for a combined diagnostic approach of histopathologic and dermoscopic evaluation. Arch Dermatol 2005; 141: 209-211.
45. Lodha S, Saggar S, Celebi J, Silvers D. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol 2008; 35: 349-352.
46. FDA. 2012. U.S. Food and Drug Administration, difference between diagnostic and adjunct diagnostic test. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/GeneralandPlasticSurgeryDevicesPanel/UCM263807.pdf (accessed 18 September 2012).